Surgery
Volume 131, Issue 6 , Pages 654-662 , June 2002

Attenuation of renal ischemia-reperfusion injury by FR167653 in dogs

,Accepted 3 March 2002.

References 

  1. Tanabe K, Oshima T, Tokumoto T, Ishikawa N, Kanematsu A, Shinmura H, et al.  Long-term renal function in non-heart-beating donor kidney transplantation: a single-center experience. Transplantation. 1998;66:1708–1713
  2. Hoshinaga K, Shiroki R, Fujita T, Kanno T, Naide Y. The fate of 359 renal allografts harvested from non-heart beating cadaver donors at a single center. Clin Transpl. 1998;213–220
  3. Lee CM, Carter JT, Randall HB, Hiose R, Stock PG, Melzer JS, et al.  The effect of age and prolonged cold ischemia times on the national allocation of cadaveric renal allografts. J Surg Res. 2000;91:83–88
  4. Bryan CF, Luger AM, Martinez J, Muruve N, Nelson PW, Pierce GE, et al.  Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft. Transplantation. 2001;71:875–879
  5. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation. 1995;59:565–572
  6. Shackleton CR, Ettinger SL, McLoughlin MG, Scudamore CH, Miller RR, Keown PA. Effect of recovery from ischemic injury on class I and class II MHC antigen expression. Transplantation. 1990;49:641–644
  7. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation. 1990;49:201–207
  8. Ibrahim S, Jacobs F, Zukin Y, Enriquez D, Holt D, Baldwin W, et al.  Immunohistochemical manifestations of unilateral kidney ischemia. Clin Transplant. 1996;10:646–652
  9. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest. 1997;99:2682–2690
  10. Kobayashi J, Takeyoshi I, Ohwada S, Iwanami K, Matsumoto K, Muramoto M, et al.  The effects of FR167653 in extended liver resection with ischemia in dogs. Hepatology. 1998;28:459–465
  11. Kamoshita N, Takeyoshi I, Ohwada S, Iino Y, Morishita Y. The effects of FR167653 on pulmonary ischemia-reperfusion injury in dogs. J Heart Lung Transplant. 1997;16:1062–1072
  12. Aiba M, Takeyoshi I, Sunose Y, Iwazaki S, Tsutsumi H, Ohwada S, et al.  FR167653 ameliorates pulmonary damage in ischemia-reperfusion injury in a canine lung transplantation model. J Heart Lung Transplant. 2000;19:879–886
  13. Otani Y, Takeyoshi I, Koibuchi Y, Matsumoto K, Muramoto M, Morishita Y. The effect of FR167653 on pulmonary ischemia-reperfusion injury in rats. J Heart Lung Transplant. 2000;19:377–383
  14. Koyano T, Takeyoshi I, Takahashi T, Hasegawa Y, Ishikawa S, Matsumoto K, et al.  Effects of FR167653 on ischemia-reperfusion injury: evaluation through preservation and transplantation in canine hearts. J Heart Lung Transplant. 1998;17:1247–1254
  15. Takeyoshi I, Iwanami K, Ohwada S, Kawashima Y, Kawata K, Aiba M, et al.  Effect of FR167653 on small bowel ischemia-reperfusion injury in dogs. Dig Dis Sci. 1999;44:2334–2343
  16. Yamamoto H, Sugitani A, Kitada H, Arima T, Nishiyama K, Motoyama K, et al.  Effect of FR167653 on pancreatic ischemia-reperfusion injury in dogs. Surgery. 2001;129:309–317
  17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159
  18. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation. 1983;35:198–204
  19. Daemen MA, van de Ven MW, Heineman E, Buurman WA. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation. 1999;67:792–800
  20. Kelly KJ, Williams WW, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, et al.  Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996;97:1056–1063
  21. Basile DP, Liapis H, Hammerman MR. Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. Am J Physiol. 1997;272:F640–F647
  22. Finn WF. Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat. Circ Res. 1980;46:440–448
  23. Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M. Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol. 1996;314:137–142
  24. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739–746
  25. Yamamoto N, Sakai F, Yamazaki H, Sato N, Nakahara K, Okuhara M. FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor- alpha, ameliorates endotoxin-induced shock. Eur J Pharmacol. 1997;327:169–174
  26. Boswell JM, Yui MA, Burt DW, Kelley VE. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol. 1988;141:3050–3054
  27. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation. 1997;64:190–197
  28. Donnahoo KK, Shames BD, Harken AH, Meldrum DR. Review article: the role of tumor necrosis factor in renal ischemia- reperfusion injury. J Urol. 1999;162:196–203
  29. Garcia-Criado FJ, Eleno N, Santos-Benito F, Valdunciel JJ, Reverte M, Lozano-Sanchez FS, et al.  Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation. 1998;66:982–990
  30. Mizutani A, Okajima K, Uchiba M, Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood. 2000;95:3781–3787
  31. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, et al.  Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem. 1997;272:19943–19950
  32. Yin M, Buurman WA, Daemen JW, Kootstra G. The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia. Transplantation. 1996;61:1443–1446
  33. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 1990;85:1936–1943
  34. Yamada T, Murase N, Maeda T, Ye Q, Sakamoto T, Terakura M, et al.  Protective effect of TNF-alpha and IL-1 beta inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation. Transplant Proc. 1998;30:2638
  35. Bonventre JV. Mechanisms of ischemic acute renal failure [clinical conference]. In: Kidney Int. 43:1993;p. 1160–1178

☆ Reprint requests: Atsushi Sugitani, MD, PhD, Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka 812-8582, Japan.

PII: S0039-6060(02)00009-0

doi: 10.1067/msy.2002.124629

Surgery
Volume 131, Issue 6 , Pages 654-662 , June 2002

Article Tools

* Image Usage & Resolution